* A corporate client of Hybridan LLP.
** Potential means Intention to Float (ITF) or similar announcement has been made.
***Arranged by type of listing and date of announcement.
****Alphabetically arranged and priced on Share Price and Market Capitalisation during the time of writing on the day of Publication.
Dish of the Day
Admissions:
None
Delistings:
Cyanconnode Holdings (CYAN.L) left AIM
Banquet Buffet****
London Stock Exchange: Main Market and AIM
First Development Resources 1.65p £3.27m (FDR.L)
The Australian-focused exploration Company reported assay results from its initial Reverse Circulation drilling programme at the Lander West gold target within the Selta Project in the Northern Territory. The eight-hole, 1,593 metre programme has confirmed primary gold (Au) mineralisation in bedrock at Lander West. Hole 26LWR08 returned 7m @ 0.40 g/t Au from 50m downhole, including 2m @ 0.98 g/t Au, with a peak 1m assay of 1.11 g/t Au. Importantly, the drilling has provided FDR with significant new geological information which, when integrated with surface geochemistry, modern geophysics and the reconstructed historical exploration dataset, has materially advanced the Company's understanding of Lander West.
Haydale 0.34p £24.68m (HAYD.L)
The advanced materials and clean-technology Company announces successful application testing of its patented Super-Efficient Thermal Transfer Fluid, together with the signing of agreements with Liquitherm Technologies Group Limited, trading as DC Cooling Solutions, and Levidian Nanosystems Limited, establishing the supply chain and route to market. The Company and its commercial partners are in advanced discussions with data-centre operators representing approximately 200MW of capacity, with first installations targeted within twelve months. SETTF is designed to remove the thermal-performance penalty caused by adding glycol to data-centre cooling systems. In testing, SETTF achieved a thermal conductivity approximately 28 per cent. above that of the baseline inhibited glycol coolant, restoring it to the level of pure water while retaining the freeze, corrosion and fouling protection for which glycol is required.
ICFG Limited 29.00p £57.11m (ICFG.L)
The international financial services Company reported its interim results for the six months ended 30 June. The Group delivered strong growth in lending and underlying profitability alongside an improvement in early-stage asset quality, while continuing to strengthen its funding base and position the business for further growth. Net operating income increased by 30% to USD32.4m (H1-25: USD 24.9m) and adjusted profit for the Period increased by 34% to USD 15.4m (H1-25 restated: USD 11.5m). In Mongolia, the Group remained the country's largest non-bank financial institution and increased its market share to 12.7% (31 December 2025: 11.4%). InvesCore NBFI JSC also celebrated its 10th anniversary during the Period, having disbursed more than USD 4.65bn of financing and supported over 13,000 SMEs since inception.
Imaging Biometrics Limited 0.78p £1.57m (IBAI.L)
The investment Company announced that its wholly owned US subsidiary, Imaging Biometrics LLC, has entered into an annual subscription agreement with a health system for IB's quantitative neuro-oncology imaging software including IB Neuro, IB Delta T1, and IB FTBx. The healthcare organisation is among the first in the region to provide access to IB's advanced quantitative MRI technologies, bringing objective, standardised imaging biomarkers to neuro-oncology care and supporting more informed clinical decision-making throughout the patient journey.
Personal Group Holdings 407.50p £127.23m (PGH.L)
The workforce benefits and insurance provider announced its interim results for the six months ended 30 June. The first six months saw strong performance across the Business with record insurance sales driving double digit revenue growth and a 22% increase in adjusted EBITDA to £6.7m. The Group has delivered basic EPS of 12.3p, a 28% increase versus H1 2025, while return on tangible equity of 29.6% demonstrates the attractive earnings power of the business model. The Group’s increasing annualised recurring revenue streams provide confidence for the remainer of FY26 and beyond and has enabled the Board to recommend a 10% increase in the 2026 Interim Dividend. Trading in Q3 has remained in line with management’s expectations to date, combined with the Group’s growing recurring revenues, underpins the Board’s confidence in achieving market expectations for the full year.
Sancus Lending Group Limited 1.05p £10.74m (LEND.L)
The finance provider released its Interim Results for the six month period ended 30 June. The Company reported an operating loss of £(3.4m) for the first six months of the year, reflected by the impact of the geopolitical and macro-economic backdrop on activity levels and funding and liquidity costs. At the same time, the business continued to make controlled progress in its core markets, increasing AUM to £339m (31 December 2025: £307m; 30 June 2025: £258.8m) and delivering Group revenue of £13.1m, a 36% increase on H1 2025. Cash was £5.99m at the end of the period.
Tertiary Minerals 0.07p £4.65m (TYM.L)
The mineral exploration and development Company announced additional laboratory analytical results from the recent Phase 4 drill programme at the Discovery Zone in Target A1, Mushima North Project in Zambia. All thirteen holes intersected near surface, silver-copper-zinc mineralisation, with several holes ending in mineralisation and thus extending the mineralisation at depth, including the best silver-copper intersection to date on the Project. Mushima North is located in the prospective Iron-Oxide-Copper-Gold region of Zambia. Target A1 is a polymetallic, silver-copper-zinc prospect, where the Company has previously reported a near surface Exploration Target of 15-30 million tonnes at 40-60 g/t silver equivalent, and which is located 28km to the east of the historic Kalengwa copper-silver mine which is currently under redevelopment.
Transense Technologies 45.50p £6.77m (TRT.L)
The provider of specialist sensor systems and smart tyre management technology through its Translogik division announced that it has secured a development and supply contract with Continental, one of the largest tyre manufacturers, for a next-generation digital tyre management tool. Under this agreement, Translogik will develop a bespoke version of its handheld TLGX device, incorporating specific enhanced functionality to meet Continental's operational requirements. Subject to completion of the development project, the Transense board expects the programme to generate annual revenues of more than £0.7m from future deployments, underpinning significant long-term growth for the Company’s Translogik division.
Unicorn Mineral Resources 7.75p £3.2m (UMR.L)
The mineral and previous metals Company announced the signing of a formal Share Purchase Agreement (SPA) to acquire a 75% interest in Q Global Copper Namibia Ltd (QGC) which holds two granted Exclusive Prospecting Licences (EPL5851 and EPL7958) covering 6,536 hectares in the Kalahari Copperbelt, comprising the historic Klein Aub Copper Mine, its surface resources, and extensive exploration potential. The SPA positions Unicorn to transition from an explorer to a near-term base metals producer targeting cash-generative processing of surface resources. The investment provides access to 5.5m tonnes of historical surface tailings, with an inhouse estimate of 0.24% Cu and 7.4 g/t Ag, and approximately 100k tonnes of high-grade surface slimes. Unicorn estimates 1.34% Cu and 33.55 g/t Ag, drastically lowering processing lead times and capital expenditure requirement compared to greenfield developments.
Zanaga Iron Ore Company Limited 3.99p £37.66m (ZIOC.L)
The Iron Ore Company Limited provided an update on the bulk sampling programme at its Zanaga Iron Ore Project in the Republic of Congo. As part of the Programme, approximately 30,000 tonnes of ore is being extracted to assemble 100 tonnes of composite sample of the hematite zone targeted for Stage 1's 12Mtpa operations. This 100 tonne sample will be sent for subsequent metallurgical testing in order to conduct pilot scale test work to confirm Zanaga's revised Direct Reduced Iron processing flowsheet at a larger scale, and provide adequate quantities of concentrates for specification characterisation, process engineering design, and product testing with steel mill customers, independent laboratories and offtakers.
What’s baking in the oven?
Potential IPOs:***
5th August: 1947 Oil & Gas, the newly incorporated oil and gas production Company focused on acquiring, operating and growing a portfolio of producing assets in the US, announced its intention to IPO onto AIM. In connection with Admission, the Company has entered into a conditional agreement to acquire Renaissance Offshore, LLC, a privately held, Houston-based oil and gas production Company with interests in eleven fields located in the shallow-water Gulf of America. The Company is raising an updated amount of £40m and the expected market capitalisation of the Company on Admission will be £70m. Admission is expected to occur in mid-September.
Dual List:***
18th August: Aimia Inc. (TSX: AIM; JSE: AII) the Canadian diversified conglomerate announced plans to dual list on AIM. It owns a selection of businesses which include: (i) an 100% interest in Cortland International Inc., a global designer, manufacturer and supplier of synthetic fiber ropes, nets, slings and tethers; a 10.85% indirect stake in Clear Media Limited, the largest operator of bus shelter advertising panels in China; and iii) the Company holds a portfolio of publicly listed securities amounting C$12m as of 30 June 2026. No capital is expected to be raised on Admission and deal details remain TBC.
Expected first day of dealings 22 September.
Status of this Note and Disclaimer
This document has been provided as a general market commentary and is issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as investment advice; a recommendation; an offer to sell; nor solicitation of any offer to buy any security or other financial instrument. Nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. The information has been provided without taking into account the investment objective, financial situation or needs of any particular person. Recipients should make their own investment decisions based upon their own financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
As market commentary, this document is not investment research or a research recommendation for regulatory purposes as it does not constitute substantive research or analysis. It is not subject to any prohibition on dealing ahead of the dissemination of investment research although Hybridan LLP maintains related internal systems and controls in connection with such dealing.
This document should not be relied upon as being an independent or impartial view of the subject matter. The individuals who prepared this document may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result, both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
This document is not intended to be an invitation or inducement to engage in investment activity. In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are categorised by Hybridan LLP as either a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority's Conduct of Business Sourcebook) (all such persons referred to in (i) and (ii) together being referred to as "relevant persons"). This document must not be acted on or relied up on by persons who are not relevant persons. For the avoidance of doubt, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority's Conduct of Business Sourcebook.
The information contained in this document is based on materials and sources that are believed to be reliable; however, they have not been independently verified and are not guaranteed as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. The information may contain projections or other forward-looking statements regarding future events, targets or expectations. There is no assurance that such events or expectations will be achieved, and actual results may be significantly different from that shown here. The information is based on current market conditions, which will fluctuate and may be superseded by subsequent market events or for other reasons. Any and all opinions expressed are current opinions as of the date appearing on this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein.
References to specific securities, asset classes and financial markets are for illustrative purposes only. Past performance is no guarantee of future results. Information and opinions presented have been obtained or derived from sources which Hybridan LLP reasonably believed to be reliable however no representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information in this document nor should it be relied upon as such.
To the fullest extent permitted by law, none of Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings shall have any liability whatsoever for any losses arising in any way from use of all or any part of the information in this document including, for the avoidance of doubt, direct or indirect or consequential loss or damage (including lost profits).
Neither this document nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom or any other jurisdiction in any part of the world.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication.
In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
Unless otherwise stated, Hybridan LLP owns the intellectual property rights and any other rights in this document. This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.
The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).
Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.
Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
If you would like to unsubscribe, please email enquiries@hybridan.com with “unsubscribe me”.
